Review Supports Dexrazoxane Use for Cardioprotection
- OPACC
- Nov 7, 2016
- 1 min read
The practice of giving dexrazoxane to protect the hearts of pediatric patients receiving anthracycline chemotherapy is supported by a review published in the British Journal of Clinical Pharmacology.
Comments